Dark
Light
Today: September 30, 2024

Adrian Johnson

Record Biopharma VC Funding in Q2 2022

TLDR: Venture capital funding in biopharma reached $9.2 billion in Q2 2024, the highest quarterly level since 2022. Emerging technologies like CRISPR, oncolytic virus therapies, obesity treatments, and AI-driven platforms are attracting
August 23, 2024
1 49 50 51 52 53 678
Go toTop